DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ: DMAA · FINANCIAL SERVICES · SHELL COMPANIES
$10.53
-0.28% today
Updated 2026-04-30
Market cap
$355.55M
P/E ratio
55.50
P/S ratio
—
EPS (TTM)
$0.19
Dividend yield
—
52W range
$10 – $11
Volume
0.2M
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2024 |
|---|---|
| Total assets | $550.00 |
| Cash & equivalents | $1351.00 |
| Current assets | $4991.00 |
| Total liabilities | $795.00 |
| Current liabilities | $795.00 |
| Long-term debt | — |
| Shareholder equity | $-244.00 |
| Retained earnings | $-279.00 |
| Accounts receivable | — |
| Inventory | — |
| Goodwill | — |